Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
For the latest in critical pharmaceutical industry news, tap into a vast store of timely articles from Pharma Intelligence. With depth and breadth of coverage unparalleled in the industry, our articles span every aspect of medical and pharmaceutical news, covering all facets of pharma today. Whatever topic is most critical to you, you’ll find expert coverage of current pharmaceutical news from our dedicated teams of experts stationed around the globe.
100+ Total results for product and free and sample content found
Scrip
The companies are combining their technologies to seek neutralizing antibody therapeutics that could prevent or treat COVID-19, building on their previous partnership in monitoring minimal residual disease in blood cancers.
Topic Coronavirus
Scrip
Fears over shortages of drugs needed for ventilated patients rise, while Merck & Co, Pfizer and Lilly allow their medics to volunteer, and attention turns to beta-interferon products and NK cell therapies to fight the virus.
Topic Coronavirus
Pink Sheet
The regulatory agency also urges qualified persons at drug companies to let the agency know as soon as possible if they are finding that the new measures are not flexible enough to deal with the current logistical challenges quickly.
Pink Sheet
Guidelines for US health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
Topic Coronavirus
Scrip
Company suspends enrolment to trials as coronavirus travel restrictions bite.
Topic Coronavirus
Scrip
News from around the biopharma sector and its efforts to meet the challenges posed by the coronavirus pandemic.
Topic Coronavirus
Skipta
Making the most of today’s pharma marketing budgets can be tricky: you’re expected to deliver more, often with fewer resources. Explore the strategies most effective for getting your product or brand in front of the right healthcare professionals (HCPs) in this free white paper from Skipta.
Generics Bulletin
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Topic Coronavirus
HBW Insight
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
Topic Coronavirus
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
